Cancer survival rates in the United States have reached a historic milestone, with 70% of patients now surviving at least five years after diagnosis. That’s a dramatic improvement from the mid-1970s, when the five-year survival rate hovered around just 50%, according to the American Cancer Society’s 2026 Cancer Statistics report.
Progress Amid Ongoing Challenges
The improved survival rates represent what experts are calling a transformational shift in cancer treatment outcomes. “When we look at people who are surviving with cancer for at least five years, that number has doubled since the 1990s,” said Dr. William Dahut, chief scientific officer of the American Cancer Society, during a press conference. “This progress is really transformational. We are seeing these gains in myeloma, melanoma, liver cancer, and even lung cancer. Today, seven in 10 people diagnosed with cancer can expect to live at least five years, and this has a meaningful impact.”
But the fight is far from over. The same report projects approximately 2,114,850 new cancer cases will be diagnosed in 2026 — about 5,800 each day — with an estimated 626,140 Americans expected to die from the disease this year, according to the ACS data.
What’s behind this remarkable improvement in survival rates? Advances in early detection, more effective treatments, and better understanding of cancer biology have all contributed to the steady climb in survival statistics for patients diagnosed between 2015 and 2021, experts say.
A Historic Publication
The American Cancer Society has been tracking these trends for generations. The organization has published its Cancer Facts & Figures report annually since 1951, making it one of the longest-running and most comprehensive resources on cancer statistics in the United States.
This year’s edition provides a wealth of data beyond survival rates, including detailed statistics on prevention, early detection, and treatment advances across different cancer types.
“The 70% five-year survival rate represents a significant milestone in our nation’s fight against cancer,” said Dr. Dawn Hershman of Columbia University Irving Medical Center, who wasn’t involved in producing the report but commented on its findings. “It reflects decades of investment in research, prevention, and treatment innovation.”
The Broader Picture
Despite the encouraging survival trends, cancer remains the second leading cause of death in the United States. The projection of more than 2.1 million new cases in 2026 (excluding non-melanoma skin cancers) translates to a staggering 5,800 diagnoses every single day, documents show.
The full report, published in CA: A Cancer Journal for Clinicians, provides a detailed breakdown by cancer type, demographic factors, and geographic regions across the United States, offering crucial insights for healthcare planning and resource allocation.
Still, the overall trend is undeniably positive. The current 70% survival rate marks a substantial improvement from the 50% rate recorded in the mid-1970s, reflecting steady progress over nearly five decades.
The survival gains haven’t been uniform across all cancer types, however. Some cancers have seen dramatic improvements, while others continue to present significant treatment challenges.
For millions of Americans living with or beyond cancer, the improved survival statistics represent more than just numbers — they translate into additional years with loved ones, milestones celebrated, and lives reclaimed from a disease that once carried a much grimmer prognosis.
